Recent 8-K filings for AXTI

• May 15, 2026, 7:05 AM ET other material materiality 0.30 neutral item 8.01item 9.01

  AXT adjourns 2026 annual meeting due to lack of quorum; reconvenes June 4, 2026

  Only 48% of outstanding shares were represented at the May 14 meeting, failing quorum.

• April 30, 2026, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01 ◈ Earnings Releases

  AXT Q1 revenue $26.9M, gross margin 29.6%; completes $632.5M capital raise for indium phosphide expansion

  Revenue $26.9M, up 16.6% QoQ and 38.7% YoY; GAAP net loss narrows to $0.03/share.

• April 21, 2026, 7:59 PM ET other material materiality 0.75 neutral item 1.01item 8.01item 9.01 ◈ Material Agreements

  AXT prices $550M public offering of 8.56M shares at $64.25; proceeds for InP capacity expansion

  Public offering of 8,560,311 shares at $64.25/share for ~$550M gross; underwriters have 30-day option for up to 1,284,046 additional shares.

• April 20, 2026, 7:59 PM ET earnings materiality 0.60 negative item 2.02 ◈ Earnings Releases

  AXT pre-announces Q1 2026 revenue $26-28M, net loss $1.6-2.6M

  Preliminary Q1 2026 revenue range $26-28 million, net loss $1.6-2.6 million.

• February 19, 2026, 6:59 PM ET earnings materiality 0.70 negative item 2.02item 9.01

  AXT reports Q4 revenue down 18% QoQ; FY2025 net loss widens to $21.3M

  Q4 revenue $23.0M, down 18% QoQ from $28.0M; GAAP EPS loss $0.08 vs $0.04 loss Q3.

• January 29, 2026, 6:59 PM ET leadership materiality 0.35 neutral item 5.02

  AXT board declares LeBlanc independent, appoints him Audit Committee chair

  Board re-evaluated Leonard J. LeBlanc's independence on Jan. 26, 2026, and found him independent under Nasdaq rules.

• January 9, 2026, 6:59 PM ET other material materiality 0.75 negative item 2.02item 7.01item 9.01

  AXT revises Q4 2025 revenue to $22.5-23.5M on China export permit delays

  Q4 2025 revenue expected $22.5-23.5M; fewer China export permits for indium phosphide than expected.

• December 30, 2025, 6:59 PM ET other material materiality 0.75 neutral item 1.01item 8.01item 9.01 ◈ Material Agreements

  AXT prices $87M public offering of 7.1M shares at $12.25; over-allotment fully exercised for $13M additional

  Underwriting agreement for 7,098,492 common shares at $12.25/share; gross proceeds ~$87M from base offering.

• October 30, 2025, 7:59 PM ET earnings materiality 0.70 positive item 2.02item 9.01

  AXT reports Q3 revenue $28.0M, net loss $1.9M; indium phosphide up 250% QoQ

  Revenue $28.0M vs $18.0M Q2'25 and $23.6M Q3'24.

• August 19, 2025, 7:59 PM ET regulatory materiality 0.75 positive item 7.01

  AXT subsidiary receives China export permits for indium phosphide; expects millions in Q3 revenue

  Beijing Tongmei Xtal Technology received export permits from China's Ministry of Commerce to resume shipping indium phosphide substrates.

• August 4, 2025, 7:59 PM ET leadership materiality 0.30 neutral item 5.02item 9.01

  AXT appoints Leonard J. Leblanc to Board to fill vacancy; Jesse Chen named Audit Committee Chair

  Leonard J. Leblanc appointed as Class III director effective July 29, 2025, to fill vacancy from Christine Russell's passing.

• July 31, 2025, 7:59 PM ET earnings materiality 0.80 negative item 2.02item 9.01

  AXT Q2 2025 revenue $18M, net loss $7M; GaAs export delays and China sluggishness

  Revenue $18.0M, down 36% YoY from $27.9M; QoQ down from $19.4M.

• July 24, 2025, 7:59 PM ET regulatory materiality 0.60 negative item 3.01item 9.01 ◈ Listing & Compliance Notices

  AXT corrects 8-K to show Nasdaq notice date for audit committee non-compliance

  Nasdaq notified AXT on July 18, 2025 that audit committee has only two independent directors after Christine Russell's passing.

• July 23, 2025, 7:59 PM ET regulatory materiality 0.45 negative item 3.01item 9.01 ◈ Listing & Compliance Notices

  AXT non-compliant with Nasdaq audit committee rules after director death; cure period through mid-2026

  Passing of director Christine Russell left Audit Committee with only two independent directors, violating Nasdaq Rule 5605(c)(2)(A).

• July 18, 2025, 7:59 PM ET regulatory materiality 0.40 neutral item 3.01item 9.01 ◈ Listing & Compliance Notices

  AXT reports board director death; Audit Committee now non-compliant with Nasdaq rule

  Christine Russell, independent director and Audit Committee Chair, passed away on July 11, 2025.

• July 9, 2025, 7:59 PM ET earnings materiality 0.75 negative item 2.02item 7.01item 9.01

  AXT cuts Q2 revenue guidance to $17.5-18M on export permit delays and weak China demand

  Preliminary Q2 2025 revenue $17.5-18M, below prior guidance of $20-22M.

• June 11, 2025, 7:59 PM ET regulatory materiality 0.75 positive item 7.01item 9.01

  AXT subsidiary receives initial export permits for indium phosphide from China

  Beijing Tongmei Xtal Technology, AXT subsidiary, received initial export permits from China's Ministry of Commerce.

• May 16, 2025, 7:59 PM ET other material materiality 0.30 neutral item 5.02item 5.07item 9.01

  AXT stockholders approve 2025 Equity Incentive Plan, elect director at annual meeting

  Christine Russell elected Class III director with 94.9% of votes cast (14,621,153 For, 779,476 Withheld).

• May 1, 2025, 7:59 PM ET earnings materiality 0.80 negative item 2.02item 9.01

  AXT Q1 2025 revenue $19.4M; GAAP gross margin -6.4%; net loss $0.20/share

  Revenue $19.4M, down 23% sequentially from $25.1M and 15% YoY from $22.7M.

• February 20, 2025, 6:59 PM ET earnings materiality 0.60 positive item 2.02item 9.01

  AXT reports FY2024 revenue up 31% to $99.4M; Q4 net loss of $5.1M widens sequentially

  FY2024 revenue $99.4M (up 31% YoY); GAAP net loss $11.6M ($0.27/share) improves from $17.9M loss.

• October 31, 2024, 7:59 PM ET earnings materiality 0.65 negative item 2.02item 9.01

  AXT Q3 revenue $23.6M, down sequentially; net loss $0.07/share, YoY improvement

  Revenue $23.6M, -15% QoQ from $27.9M, +36% YoY from $17.4M.

• August 1, 2024, 7:59 PM ET earnings materiality 0.65 positive item 2.02item 9.01

  AXT Q2 revenue $27.9M, up 50% YoY; net loss narrows to $0.04 per share

  Revenue $27.9M, +23% sequential and +50% YoY; GAAP net loss $1.5M ($0.04/sh) vs $5.1M loss a year ago.

• May 20, 2024, 7:59 PM ET other material materiality 0.55 neutral item 5.02item 5.07item 9.01

  AXTI shareholders approve 3.6M share increase to equity plan; re-elect Jesse Chen

  Stockholders approved amendment to 2015 Equity Incentive Plan to increase reserved shares by 3,600,000.

• May 2, 2024, 7:59 PM ET earnings materiality 0.65 positive item 2.02item 9.01 ◈ Earnings Releases

  AXT Q1 revenue $22.7M, up 11% QoQ; IP substrates up 48%; net loss narrows

  Revenue $22.7M, up 11% sequentially and 17% YoY; GAAP net loss ($2.1M) / ($0.05) vs ($3.6M)/$0.09 in Q4.

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.80 · Median 0.65 · Most common event earnings

7 positive 9 negative 8 neutral

source · AXTI on sec.gov